Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Fidelio Capital in connection with the acquisition of Veterinary Orthopedic Implants, Inc.
Mandate

Vinge advises Fidelio Capital in connection with the acquisition of Veterinary Orthopedic Implants, Inc.

May 22, 2020 Banking and Finance M&A EU, Competition and Regulatory

Vinge has advised Fidelio Capital on the acquisition of Veterinary Orthopedic Implants, Inc (“VOI”).

VOI is a fast-growing US company within the market for veterinary orthopedic implants and instruments.

Vinge’s team consisted of, among others, Jonas Bergström, Manne Bergström, Johanna Wiberg and Carl-Fredrik Wachtmeister (M&A/Corporate), Albert Wållgren and Axel Jansson (Banking and Finance), Johan Karlsson, Sebastian Örndahl and Lisa Malmborg (Competition) and Christoffer Widström (VDR-specialist).

Related

Vinge advises Greenfood

 Vinge advises Greenfood in connection with the divestment of its Fresh Produce business to Dole.
October 21, 2026

Vinge has advised Investor in connection with acquisition of shares in EQT

 Vinge has advised Investor in connection with an acquisition of 12,500,000 shares in EQT AB from Wallenberg Investments for a total consideration of approximately SEK 3.5 billion.
October 19, 2026

Vinge has advised Oncopeptides in connection with a directed share issue

 Vinge has advised Oncopeptides in connection with a directed share issue, whereby Oncopeptides raises proceeds of SEK 100 million.
October 16, 2026